Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin in male patients with lower urinary tract syndrome
NCT00239317Phase 3Completed
- Sponsor
- Astellas Pharma
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Micturition disorder comparing Tamsulosin Arm with Placebo Arm (2 arms). Primary endpoint: International Prostate Symptom Score at 8 weeks. Status: completed.
02
Drugs
tamsulosin
03
Conditions
Micturition disorder
Beyond the preview
Go deeper on NCT00239317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239317.